Impaired T cell proliferation by

Animals Azepines / pharmacology Benzodiazepines / pharmacology Cell Differentiation Cell Line, Tumor Cell Proliferation Cells, Cultured Epigenesis, Genetic Immunotherapy, Adoptive / methods Indolizines / pharmacology Melanoma, Experimental / therapy Mice Mice, Inbred C57BL Sulfones / pharmacology T-Lymphocytes / cytology Triazoles / pharmacology
BET inhibition Cancer immunotherapy T cell differentiation adoptive cell therapy cytotoxic T lymphocytes melanoma

Journal

Epigenetics
ISSN: 1559-2308
Titre abrégé: Epigenetics
Pays: United States
ID NLM: 101265293

Informations de publication

Date de publication:
Historique:
pubmed: 20 8 2019
medline: 22 4 2021
entrez: 20 8 2019
Statut: ppublish

Résumé

Activation of naïve CD8

Identifiants

DOI: 10.1080/15592294.2019.1656156 PMID: 31423932 PMC: PMC6961692
pubmed: 31423932
doi: 10.1080/15592294.2019.1656156
pmc: PMC6961692
doi:

Substances chimiques

(+)-JQ1 compound 0
1-(1-(3-(methylsulfonyl)phenyl)-7-propoxyindolizin-3-yl)ethanone 0
Azepines 0
Indolizines 0
Sulfones 0
Triazoles 0
Benzodiazepines 12794-10-4
molibresib 5QIO6SRZ2R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

134-144

Références

Cell. 2011 Sep 16;146(6):904-17
pubmed: 21889194
Cancer Cell. 2011 Jul 12;20(1):53-65
pubmed: 21741596
Oncotarget. 2017 Sep 27;8(58):98348-98359
pubmed: 29228694
Blood. 2016 Jul 28;128(4):519-28
pubmed: 27226436
Oncol Rep. 2015 Aug;34(2):663-72
pubmed: 26035691
N Engl J Med. 2016 Dec 8;375(23):2255-2262
pubmed: 27959684
Blood. 2007 Jan 1;109(1):31-9
pubmed: 16960145
Immunol Cell Biol. 2002 Apr;80(2):156-63
pubmed: 11940116
Nat Med. 2011 Sep 18;17(10):1290-7
pubmed: 21926977
Nat Rev Immunol. 2018 May;18(5):340-356
pubmed: 29379213
Oncoimmunology. 2015 Apr 2;4(8):e1019198
pubmed: 26405572
Science. 2015 Apr 3;348(6230):62-8
pubmed: 25838374
J Invest Dermatol. 2009 Dec;129(12):2835-42
pubmed: 19554023
Clin Cancer Res. 2015 Nov 1;21(21):4767-73
pubmed: 26362997
Curr Opin Immunol. 2016 Apr;39:90-5
pubmed: 26829458
Nat Rev Cancer. 2012 Oct;12(10):671-84
pubmed: 22996603
J Immunother. 2012 Nov-Dec;35(9):651-60
pubmed: 23090074
Oncologist. 2007 Oct;12(10):1247-52
pubmed: 17962618
J Immunol. 2004 Dec 15;173(12):7125-30
pubmed: 15585832
J Immunol. 1998 Nov 15;161(10):5338-46
pubmed: 9820507
Cancer Immunol Res. 2017 Oct;5(10):908-919
pubmed: 28851693
Nat Med. 2009 Jul;15(7):808-13
pubmed: 19525962
J Immunother Cancer. 2014 Apr 15;2:8
pubmed: 25054063
J Immunol. 2005 Mar 1;174(5):2919-25
pubmed: 15728503
Haematologica. 2010 Apr;95(4):613-21
pubmed: 20133897
Oncoimmunology. 2019 Jun 3;8(8):1609874
pubmed: 31413920
Cancer Res. 2002 Nov 15;62(22):6438-41
pubmed: 12438231
J Clin Invest. 2016 Sep 1;126(9):3479-94
pubmed: 27548527
Sci Rep. 2016 Aug 02;6:30749
pubmed: 27480951
Cancer Immunol Res. 2014 May;2(5):459-68
pubmed: 24795358
J Immunol. 2011 Aug 15;187(4):1542-6
pubmed: 21724993

Auteurs

Jonathan Chee (J)

Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, West Perth, WA, Australia.
National Centre for Asbestos Related Diseases, School of Biomedical Sciences, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia.
ORCID: 0000-0002-7986-2708

Chelsea Wilson (C)

Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, West Perth, WA, Australia.

Anthony Buzzai (A)

Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, West Perth, WA, Australia.

Ben Wylie (B)

Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, West Perth, WA, Australia.

Catherine A Forbes (CA)

National Centre for Asbestos Related Diseases, School of Biomedical Sciences, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia.

Mitchell Booth (M)

Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, West Perth, WA, Australia.

Nicola Principe (N)

National Centre for Asbestos Related Diseases, School of Biomedical Sciences, University of Western Australia, QEII Medical Centre, Nedlands, WA, Australia.
ORCID: 0000-0001-6458-2482

Bree Foley (B)

Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, West Perth, WA, Australia.

Mark N Cruickshank (MN)

Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, West Perth, WA, Australia.

Jason Waithman (J)

Telethon Kids Institute, Centre for Child Health Research, The University of Western Australia, West Perth, WA, Australia.

Articles similaires

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Use of organic material provided by an automatic enrichment device by weaner pigs and its influence on tail lesions.

Philipp Heseker, Jeanette Probst, Stefanie Ammer et al.
1.00
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Impaired T cell proliferation by
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azépines › Impaired T cell proliferation by
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Benzazépines › Benzodiazépines › Impaired T cell proliferation by
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Différenciation cellulaire › Impaired T cell proliferation by
questionsmedicales.fr › Cellules › Cellules cultivées › Cellules cancéreuses en culture › Lignée cellulaire tumorale › Impaired T cell proliferation by
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Processus de croissance cellulaire › Prolifération cellulaire › Impaired T cell proliferation by
questionsmedicales.fr › Cellules › Cellules cultivées › Impaired T cell proliferation by
questionsmedicales.fr › Phénomènes génétiques › Régulation de l'expression des gènes › Épigenèse génétique › Impaired T cell proliferation by
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Immunisation passive › Transfert adoptif › Immunothérapie adoptive › Impaired T cell proliferation by
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Indolizine › Impaired T cell proliferation by
questionsmedicales.fr › Techniques d'investigation › Modèles animaux › Tumeurs expérimentales › Mélanome expérimental › Impaired T cell proliferation by
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Impaired T cell proliferation by
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Rodentia › Muridae › Murinae › Souris › Lignées consanguines de souris › Souris de lignée C57BL › Impaired T cell proliferation by
questionsmedicales.fr › Composés chimiques organiques › Composés du soufre › Sulfones › Impaired T cell proliferation by
questionsmedicales.fr › Systèmes sanguin et immunitaire › Système immunitaire › Leucocytes › Agranulocytes › Lymphocytes › Lymphocytes T › Impaired T cell proliferation by
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Triazoles › Impaired T cell proliferation by